As shown in Fig. 6, Tph1 expression was markedly upregulated in both treatment groups, with CFS eliciting a robust 6.63 ± 0.94-fold induction, compared to a 3.17 ± 0.98-fold increase by EVs. Here, TPH1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.